Aurelie Moniot
Reims, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Non-clinical pharmacology, pharmacokinetics, and safety evaluation of TAX2, a first-in-class peptide targeting the TSP-1/CD47 matricellular axis.
Journal: Toxicology and applied pharmacology
Published: January 20, 2026
The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.
Journal: Molecular cancer
Published: May 13, 2024
The acute inflammatory response to copper(II)-doped biphasic calcium phosphates.
Journal: Materials today. Bio
Published: June 30, 2023
Inhibition of Recruitment and Activation of Neutrophils by Pyridazinone-Scaffold-Based Compounds.
Journal: International journal of molecular sciences
Published: June 07, 2022
Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo.
Journal: Cancers
Published: October 15, 2021
Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors.
Journal: RSC medicinal chemistry
Published: December 16, 2020
Osteoinductive Material to Fine-Tune Paracrine Crosstalk of Mesenchymal Stem Cells With Endothelial Cells and Osteoblasts.
Journal: Frontiers in bioengineering and biotechnology
Published: July 01, 2019
Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents.
Journal: European journal of medicinal chemistry
Published: October 11, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026